ABSORPTION AND EXCRETION OF PENTAZOCINE AFTER ADMINISTRATION BY DIFFERENT ROUTES

被引：20
作者：
BURT, RAP
BECKETT, AH
机构：
来源：
BRITISH JOURNAL OF ANAESTHESIA | 1971年 / 43卷 / 05期
关键词：
D O I：
10.1093/bja/43.5.427
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：427 / &
相关论文
共 23 条
[11]   INFLUENCE OF ROUTE OF ADMINISTRATION ON AREA UNDER PLASMA CONCENTRATION-TIME CURVE [J].
HARRIS, PA ;
RIEGELMA.S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (01) :71-&
[12]  
HOLLISTER LE, 1963, CLIN PHARMACOL THER, V4, P612
[13]  
JAFFE JH, 1970, PHARMACOLOGICAL BASI, P259
[14]  
KEERISZANTO M, 1970, JAMA-J AM MED ASSOC, V213, P384
[15]   PHARMACEUTICAL FORMULATION AND THERAPEUTIC EFFICACY [J].
LEVY, G ;
NELSON, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1961, 177 (10) :689-&
[16]  
LEVY G, 1967, J MOND PHARM, V3, P237
[17]   METABOLISM IN VITRO AND IN VIVO OF PENTAZOCINE [J].
PITTMAN, KA ;
ROSI, D ;
CHERNIAK, R ;
MEROLA, AJ ;
CONWAY, WD .
BIOCHEMICAL PHARMACOLOGY, 1969, 18 (07) :1673-&
[18]   DRUG METABOLISM BY INTESTINAL MICROORGANISMS [J].
SCHELINE, RR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1968, 57 (12) :2021-&
[19]  
SEARL RO, 1967, CAN MED ASSOC J, V96, P1513
[20]  
TANNENBAUM PJ, 1968, CLIN PHARMACOL THER, V9, P598
123